A well-known contract research organization (CRO) with presence across two continents wanted to enter the European market. The client’s goal was to establish and expand their services to European based pharma/biotech companies with an oncology, neuroscience and metabolic diseases pipeline. IMIHGOM was engaged to devise and lead a business development strategy to target new opportunities in 10 European countries.
IMIHGOM supports companies in their market intelligence and scouting, as a virtual extension of their business development team
IMIHGOM undertook a strategic market intelligence and scouting approach to achieve our client’s goals. An initial SWOT analysis generated a clear understanding of our client’s capabilities and enabled us to better position our client on the European market.
Our market analysis and scouting resulted in more than 60 meetings with pharma/biotech companies for our client. Many of these opportunities are progressing towards contracting. The remaining opportunities are being maintained. The client has further engaged IMIHGOM to lead these business development opportunities.